|
Volumn 23, Issue 6, 2005, Pages 914-
|
BCG as a new therapeutic and prophylactic agent in patients with severe oral aphtosis [4]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANESTHETIC AGENT;
ANTIBIOTIC AGENT;
ANTIINFLAMMATORY AGENT;
BCG VACCINE;
CD8 ANTIGEN;
HERBACEOUS AGENT;
IMMUNOMODULATING AGENT;
ADOLESCENT;
ADULT;
ALOPECIA AREATA;
ANALYSIS OF VARIANCE;
APHTHOUS STOMATITIS;
CLINICAL ARTICLE;
DELTOID MUSCLE;
DISEASE SEVERITY;
FEMALE;
FOLLOW UP;
HELPER CELL;
HERBAL MEDICINE;
HUMAN;
IMMUNOMODULATION;
IMMUNOREGULATION;
INCIDENCE;
INFECTION PREVENTION;
LEPROSY;
LETTER;
MALE;
MELANOMA;
MOUTH MUCOSA;
PATHOGENESIS;
PATIENT SELECTION;
PREVALENCE;
PRIORITY JOURNAL;
RECURRENT DISEASE;
RISK REDUCTION;
SKIN DISEASE;
SKIN LEISHMANIASIS;
STATISTICAL SIGNIFICANCE;
SUPPRESSOR CELL;
TREATMENT OUTCOME;
VERRUCA VULGARIS;
WART VIRUS;
ADOLESCENT;
ADULT;
BCG VACCINE;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
SEVERITY OF ILLNESS INDEX;
STOMATITIS, APHTHOUS;
|
EID: 29944443194
PISSN: 0392856X
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (9)
|
References (7)
|